Aspirin resistance: position paper of the Working Group on Aspirin Resistance
A.D. MICHELSON(University of Massachusetts Chan Medical School), A. Koneti Rao(Mayo Clinic in Arizona), Chiara Cerletti(Istituto Neurologico Mediterraneo), Thomas J. Kunicki(Scripps Research Institute), Kandice Kottke‐Marchant(Cleveland Clinic), Marco Cattaneo(University of Milan), Paul A. Gurbel(Sinai Hospital), John W. Eikelboom(Population Health Research Institute), Fabio M. Pulcinelli(Sapienza University of Rome)
Cited by 329
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k